GlassScriptPhysician profile
Harish Manyam
NPI 1780845032
$265,128.87
in general payments reported to CMS, 2019-2025
53 companies · $44K in 2025
The $44K reported for 2025 was more than what 94% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51K · 2020: $16K · 2021: $49K · 2022: $51K · 2023: $33K · 2024: $21K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Consulting Fee: $20K · Food and Beverage: $16K · Travel and Lodging: $13K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,572.50 |
| Consulting Fee | $20,450.00 |
| Food and Beverage | $16,449.32 |
| Travel and Lodging | $12,666.73 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $93,979.69 | 2019-2024 | Xarelto |
| Abbott Laboratories | $79,461.12 | 2019-2025 | Merlin@Home, Aveir, Amplatzer Amulet |
| Philips North America LLC | $30,107.31 | 2019-2025 | Igt Devices Undivided, Holter, (9520) Igt Devices Undivided |
| Medtronic, INC. | $25,177.90 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan, Evera Mri Xt Dr Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13,772.94 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $9,099.28 | 2019-2025 | Farapulse, Versacross Access Solution, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $3,007.55 | 2021-2025 | Camzyos |
| Biosense Webster, INC. | $2,098.94 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Atricure, INC. | $1,382.61 | 2019-2025 | Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System, Epi-Sense Guided Coagulation System With Visitrax |
| Novartis Pharmaceuticals Corporation | $1,220.27 | 2019-2025 | |
| Cordis US Corp. | $828.31 | 2021-2025 | Mynx Control Venous, Mynxgrip |
| Abiomed | $741.03 | 2019-2025 | Impella |
| Altathera Pharmaceuticals LLC | $600.00 | 2024 | Sotalol Hydrochloride |
| Shockwave Medical, INC | $392.04 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $332.17 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $322.66 | 2025 | Flowtriever |
| Pfizer INC. | $246.86 | 2019-2024 | |
| Cvrx, INC. | $242.02 | 2021-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $224.00 | 2021-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $208.48 | 2019-2025 | Farxiga, Wainua |
| Kestra Medical Technology Services, INC. | $154.51 | 2025 | Assure Wcd |
| Angiodynamics, INC. | $146.83 | 2020-2024 | Alphavac |
| Biotronik INC. | $140.56 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $125.33 | 2023 | Uptravi, Opsumit |
| Edwards Lifesciences Corporation | $103.33 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Impulse Dynamics (USA) INC. | $94.48 | 2020 | |
| Medtronic Vascular, INC. | $86.49 | 2019-2020 | |
| Amgen INC. | $77.15 | 2019-2025 | Repatha |
| Sanofi-Aventis U.S. LLC | $71.80 | 2019-2023 | |
| Alnylam Pharmaceuticals INC. | $61.94 | 2019-2023 | Amvuttra |
| Lundbeck LLC | $60.02 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $59.93 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $59.61 | 2023-2024 | Inpefa |
| Amarin Pharma, INC. | $55.93 | 2020-2022 | |
| Heartflow, INC. | $50.28 | 2025 | |
| Baxter Healthcare | $45.59 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Teleflex LLC | $43.65 | 2022 | |
| Bridgebio Pharma, INC. | $37.59 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $26.07 | 2022-2023 | Verquvo |
| Glaxosmithkline, LLC. | $25.51 | 2024 | Zejula |
| Bayer Healthcare Pharmaceuticals INC. | $20.89 | 2021 | |
| Akcea Therapeutics, INC. | $20.45 | 2019 | |
| Cardiva Medical, INC. | $19.57 | 2025 | Optowire |
| Astellas Pharma US INC | $18.34 | 2019 | |
| Bardy Diagnostics, INC. | $16.00 | 2020 | |
| Novo Nordisk INC | $15.78 | 2023 | Rybelsus, Ozempic |
| Esperion Therapeutics, INC. | $14.06 | 2021 | |
| Olympus America INC. | $13.99 | 2024 | Visera Elite II Video System Center |
| Portola Pharmaceuticals, LLC | $13.12 | 2019 | |
| Osprey Medical INC | $4.89 | 2020 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harish Manyam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.